176 related articles for article (PubMed ID: 25927490)
21. Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy.
Fogliata A; De Rose F; Franceschini D; Stravato A; Seppälä J; Scorsetti M; Cozzi L
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):785-793. PubMed ID: 29249528
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation.
Min CH; Paganetti H; Winey BA; Adams J; MacDonald SM; Tarbell NJ; Yock TI
Radiat Oncol; 2014 Nov; 9():220. PubMed ID: 25403752
[TBL] [Abstract][Full Text] [Related]
23. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825
[TBL] [Abstract][Full Text] [Related]
24. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma.
Bavle A; Tewari S; Sisson A; Chintagumpala M; Anderson M; Paulino AC
Pediatr Blood Cancer; 2018 Aug; 65(8):e27095. PubMed ID: 29693784
[TBL] [Abstract][Full Text] [Related]
26. Life years lost--comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale.
Brodin NP; Vogelius IR; Maraldo MV; Munck af Rosenschöld P; Aznar MC; Kiil-Berthelsen A; Nilsson P; Björk-Eriksson T; Specht L; Bentzen SM
Cancer; 2012 Nov; 118(21):5432-40. PubMed ID: 22517408
[TBL] [Abstract][Full Text] [Related]
27. Pediatric CSI: are protons the only ethical approach?
Johnstone PA; McMullen KP; Buchsbaum JC; Douglas JG; Helft P
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):228-30. PubMed ID: 23958143
[No Abstract] [Full Text] [Related]
28. Second malignant neoplasm risk after craniospinal irradiation in X-ray-based techniques compared to proton therapy.
Sakthivel V; Ganesh KM; McKenzie C; Boopathy R; Selvaraj J
Australas Phys Eng Sci Med; 2019 Mar; 42(1):201-209. PubMed ID: 30725439
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma.
Harrabi SB; Bougatf N; Mohr A; Haberer T; Herfarth K; Combs SE; Debus J; Adeberg S
Strahlenther Onkol; 2016 Nov; 192(11):759-769. PubMed ID: 27363701
[TBL] [Abstract][Full Text] [Related]
30. Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential.
Toltz A; Shin N; Mitrou E; Laude C; Freeman CR; Seuntjens J; Parker W; Roberge D
J Appl Clin Med Phys; 2015 Sep; 16(5):167–178. PubMed ID: 26699298
[TBL] [Abstract][Full Text] [Related]
31. Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer.
Fontenot JD; Lee AK; Newhauser WD
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):616-22. PubMed ID: 19427561
[TBL] [Abstract][Full Text] [Related]
32. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study.
Mu X; Björk-Eriksson T; Nill S; Oelfke U; Johansson KA; Gagliardi G; Johansson L; Karlsson M; Zackrisson DB
Acta Oncol; 2005; 44(6):554-62. PubMed ID: 16165914
[TBL] [Abstract][Full Text] [Related]
33. Three-dimensional conformal radiotherapy (3D-CRT) vs. volumetric modulated arc therapy (VMAT) in deep inspiration breath-hold (DIBH) technique in left-sided breast cancer patients-comparative analysis of dose distribution and estimation of projected secondary cancer risk.
Racka I; Majewska K; Winiecki J
Strahlenther Onkol; 2023 Jan; 199(1):90-101. PubMed ID: 35943553
[TBL] [Abstract][Full Text] [Related]
34. Acute toxicity of craniospinal irradiation with volumetric-modulated arc therapy in children with solid tumors.
Wong KK; Ragab O; Tran HN; Pham A; All S; Waxer J; Olch AJ
Pediatr Blood Cancer; 2018 Jul; 65(7):e27050. PubMed ID: 29630782
[TBL] [Abstract][Full Text] [Related]
35. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
36. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses.
Sethi RV; Giantsoudi D; Raiford M; Malhi I; Niemierko A; Rapalino O; Caruso P; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):655-63. PubMed ID: 24521681
[TBL] [Abstract][Full Text] [Related]
37. Second tumors in pediatric patients treated with radiotherapy to the central nervous system.
Galloway TJ; Indelicato DJ; Amdur RJ; Swanson EL; Smith AA; Marcus RB
Am J Clin Oncol; 2012 Jun; 35(3):279-83. PubMed ID: 21383606
[TBL] [Abstract][Full Text] [Related]
38. Out-of-field doses in pediatric craniospinal irradiations with 3D-CRT, VMAT, and scanning proton radiotherapy: A phantom study.
Majer M; Ambrožová I; Davídková M; De Saint-Hubert M; Kasabašić M; Knežević Ž; Kopeć R; Krzempek D; Krzempek K; Miljanić S; Mojżeszek N; Veršić I; Stolarczyk L; Harrison RM; Olko P
Med Phys; 2022 Apr; 49(4):2672-2683. PubMed ID: 35090187
[TBL] [Abstract][Full Text] [Related]
39. Proton therapy and helical tomotherapy result in reduced dose deposition to the pancreas in the setting of cranio-spinal irradiation for medulloblastoma: implications for reduced risk of diabetes mellitus in long-term survivors.
Brower JV; Gans S; Hartsell WF; Goldman S; Fangusaro JR; Patel N; Lulla RR; Smiley NP; Chang JH; Gondi V
Acta Oncol; 2015 Apr; 54(4):563-6. PubMed ID: 25410591
[No Abstract] [Full Text] [Related]
40. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
